Four former supervisory correctional officers at Louisiana State Penitentiary in Angola, Louisiana — Daniel Davis (43), Scotty Kennedy (52), John Sanders (34), and James Savoy, Jr. (42) — were sentenced on July 2, for their roles in assaulting an inmate who was handcuffed, shackled, and not resisting, and for conspiring to cover up their misconduct by devising a false cover story, submitting false reports documenting that cover story, tampering with witnesses, and lying under oath.

NEW ORLEANS, LOUISIANA – United States Attorney Peter G. Strasser and Makan Delrahim, Assistant Attorney General for the Antitrust Division of the Department of Justice, announced that CAJAN WELDING & RENTALS, LTD., a company located in Opelousas, Louisiana, was charged on July 2, 2020 in a one-count bill of information with conspiracy to defraud the United States and to violate the Procurement Integrity Act, in violation of 18 U.S.C. § 371.

MUSKOGEE, OKLAHOMA – The United States Attorney’s Office for the Eastern District of Oklahoma announced that Ronald Justin Johnson, age 38, of Howe, Oklahoma was sentenced to 3 years of probation and ordered to pay restitution in the amount of $150,117.68 for Conversion Of Mortgaged Property, in violation of Title 18, United States Code, Section 658. The charges arose from an investigation by the United States Department of Agriculture – Office of Inspector General (“OIG”).

          LOS ANGELES – A San Fernando Valley man was sentenced today to 259 months in federal prison for overseeing a long-running $3.3 million credit card, loan and real estate fraud scheme using stolen identities, primarily that of children.

LOUISVILLE, Ky. – United States Attorney Russell Coleman today announced an $8.25 million settlement with Agendia, Inc., a molecular diagnostics testing company based in Irvine, California, for an alleged nationwide scheme to bill Medicare for Agendia’s flagship genetic test, MammaPrint. The MammaPrint test analyzes the activity of certain genes within a breast cancer tumor to predict the risk of breast cancer recurrence in patients.